The McCAVE Trial: Vanucizumab plus mFOLFOX-6 Versus Bevacizumab plus mFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC)

  1. Bendell, J.C.
  2. Sauri, T.
  3. Gracián, A.C.
  4. Alvarez, R.
  5. López-López, C.
  6. García-Alfonso, P.
  7. Hussein, M.
  8. Miron, M.-L.L.
  9. Cervantes, A.
  10. Montagut, C.
  11. Vivas, C.S.
  12. Bessudo, A.
  13. Plezia, P.
  14. Moons, V.
  15. Andel, J.
  16. Bennouna, J.
  17. van der Westhuizen, A.
  18. Samuel, L.
  19. Rossomanno, S.
  20. Boetsch, C.
  21. Lahr, A.
  22. Franjkovic, I.
  23. Heil, F.
  24. Lechner, K.
  25. Krieter, O.
  26. Hurwitz, H.
  27. Show all authors +
Journal:
Oncologist

ISSN: 1549-490X,  1083-7159

Year of publication: 2020

Volume: 25

Issue: 3

Pages: e451-e459

Type: Article

DOI: 10.1634/THEONCOLOGIST.2019-0291 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus